Alzinova
Phase 1Today, Alzheimer’s disease affects almost every family, in every society. More than 30 million individuals are diagnosed with Alzheimer’s. Alzinova is the pioneer in the development of a vaccine that has the potential to change that.
Founded
2015
Focus
AntibodiesBiologicsVaccines
About
Today, Alzheimer’s disease affects almost every family, in every society. More than 30 million individuals are diagnosed with Alzheimer’s. Alzinova is the pioneer in the development of a vaccine that has the potential to change that.
Funding History
2Total raised: $3M
Seed$2.5MAlmi InvestJun 15, 2021
Grant$500KVinnovaJun 15, 2020
Company Info
TypePrivate
Founded2015
LocationUmeå, Sweden
StagePhase 1
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile